NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
9.32
+0.19 (2.08%)
Aug 13, 2025, 4:00 PM - Market closed
NeuroPace Employees
NeuroPace had 184 employees as of December 31, 2024. The number of employees increased by 13 or 7.60% compared to the previous year.
Employees
184
Change (1Y)
13
Growth (1Y)
7.60%
Revenue / Employee
$481,359
Profits / Employee
-$140,989
Market Cap
308.32M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 184 | 13 | 7.60% |
| Dec 31, 2023 | 171 | 4 | 2.40% |
| Dec 31, 2022 | 167 | 1 | 0.60% |
| Dec 31, 2021 | 166 | 14 | 9.21% |
| Dec 31, 2020 | 152 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NPCE News
- 1 day ago - NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - NeuroPace Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - GlobeNewsWire
- 13 days ago - NeuroPace Commends CMS for Maintaining FY25 Reimbursement Structure for Epilepsy with Neurostimulator Cases - GlobeNewsWire
- 7 weeks ago - NeuroPace Announces Strategic CFO Transition - GlobeNewsWire
- 7 weeks ago - NPCE Investors Have Opportunity to Join NeuroPace, Inc. Fraud Investigation with the Schall Law Firm - PRNewsWire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating NeuroPace, Inc. (NPCE) And Encourages Shareholders to Connect - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against NeuroPace, Inc. (NPCE) And Encourages Shareholders to Reach Out - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against NeuroPace, Inc. (NPCE) and Encourages Shareholders to Learn More About the Investigation - Accesswire